Jack was born with an eye condition known as retinitis pigmentosa associated with RPE65 gene mutations. On March 20, 2018, he was treated with a newly FDA-approved gene therapy drug known as Luxturna — and the results are life-changing.
Technology to screen newborn babies for deafness has inspired Meagan to lace up her sneakers for the Boston Marathon in support of Massachusetts Eye and Ear.
There's now an FDA-approved gene therapy drug for inherited blindness. Meet the first patient in the United States to receive it, Jack Hogan, and his care team from Mass. Eye and Ear.
100 years after a deadly explosion in Halifax, Nova Scotia, physicians reflect on all the lessons learned for disaster relief, and especially the medical advances in eye trauma.
Myles Standish sailed across the Atlantic in 1620 and joined the first Thanksgiving dinner in Plymouth in 1621. Seven generations later, another Myles Standish (1851–1928) became an ophthalmologist at Mass. Eye and Ear.
A team of physicians and music therapists study the benefits of medically-based music therapy for head and neck cancer patients.
An anonymous gift exceeding $20 million transformative for Mass. Eye and Ear, patients.
Self-made broadcast pioneer and media mogul Norman Knight has generously supported the Nursing Department at Mass. Eye and Ear for more than 20 years.
The Mass. Eye and Ear community mourns the loss of our beloved colleague, provider and friend, Dr. Lina Bolaños.
© 2019 Massachusetts Eye and Ear
